Read + Share
Amedeo Smart
Independent Medical Education
Richard F, van Lier JJ, Roubert B, Haboubi T, et al. Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers. Am J Hematol 2020;95:68-77.PMID: 31674058
Email
LinkedIn
Facebook
Twitter
Privacy Policy